Bibliografia
_________________________________________________________________
98
116. Soge OO, Queenan AM, Ojo KK, Adeniyi BA, Roberts MC. CTX-M-15
extended-spectrum β-lactamase from Nigerian Klebsiella pneumoniae. J
Antimicrob Chemother 2006; 57: (24-30).
117. Stürenburg E, Mack D. Extended-spectrum β-lactamases: implications for
the clinical microbiology laboratory, therapy, and infection control. J Infect
2003; 47:273-95. Review.
118. Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, Persing
DH, Swaminathan B. Interpreting chromosomal DNA restriction patterns
produced by pulsed-field gel eletrophoresis: criteria for bacterial strain
typing. J Clin Microbiol 1995; 33: 2233-2239. Guest Comentary.
119. Tenover FC, Raney PM, Williams PP, Rasheed JK, Biddle JW, Oliver A et
al. Evaluation of the NCCLS extended-spectrum β-actamase confirmation
methods for Escherichia coli with isolates collected during project ICARE. J
Clin Microbiol 2003; 41:3142-46.
120. Tolun V, Küçükbasmac Ö, Törümküney-Akbulut D, Çatal Ç, Ang-Küçüker
M, Ang Ö. Relationship between ciprofloxacin resistance and extended-
spectrum β-lactamase production in Escherichia coli and Klebsiella
pneumoniae strains. Clin Microbiol Infect 2004, 10:72-75.
121. Tosin I, Silbert S, Sader HS. The use of molecular typing to evaluate the
dissemination of antimicrobial resistance among Gram-negative rods in
Brazilian Hospitals. Braz J Infect Dis 2003, 7:360-69.
122. Tumbarello M, Citton R, Spanu T, Sanguinetti M, Romano L, Fadda G,
Cauda R. ESBL-producing multidrug-resistant Providencia stuartii infections
in a university hospital. J Antimicrob Chemother 2004, 53:277-82.
123. Valverde A, Coque TM, Sánchez-Moreno MP, Rollán A, Baquero F,
Cantón R. Dramatic increase in prevalence of fecal carriage of extended-
spectrum β-lactamase-producing Enterobacteriaceae during nonoutbreak
situations in Spain. J Clin Microbiol 2004, 4769-75.
124. Weldhagen GF, Poirel L, Nordmann P. Ambler class A extended-spectrum
β-lactamases in Pseudomonas aeruginosa: novel developments and clinical
impact. Antimicrob Agents Chemother 2003; 47: 2385-2392.